Lactation Outcomes Among Survivors of Pediatric Cancer

Completed

Conditions studied: Cancer, Leukemia

In brief

While the majority of women in the general population can breastfeed successfully, the investigators have limited knowledge about the correlates and sequelae of lactation success among women treated for pediatric malignancies. Childhood cancer treatments are known to cause late effects that frequently involve the endocrine system. Because normal lactation is dependent upon interplay of multiple endocrine factors, the investigators anticipate more breastfeeding difficulties in survivors that have diabetes, growth hormone deficiencies, thyroid disorders and obesity. In order to more fully inform clinicians and female survivors, the study of the burden of lactation failure is needed to begin to address the impact of pediatric cancer therapy on lactation success/failure and to examine the association of specific endocrine disorders on lactation outcomes.

Key facts

Study ID

NCT02399956

Run by

St. Jude Children's Research Hospital

People needed

471

Starts

2015-03-01

Expected to finish

2015-12-01

Last updated by the study team

2015-12-10

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Participants in the SJLIFE protocol or patients in the After Completion of Therapy (ACT) Clinic, both at St. Jude Children's Research Hospital.
• Female
• 18 years of age or older
• At least one reported live birth after childhood cancer diagnosis and treatment.

You may not qualify if…

• Unable to read and write.
• Unable to read and understand English.

Where it is running

• St. Jude Children's Research Hospital — Memphis, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.